Kronos Bio
KRON
KRON was delisted on the 20th of June, 2025.
56 hedge funds and large institutions have $25.6M invested in Kronos Bio in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.75% less ownership
Funds ownership: 36.11% → 34.36% (-1.7%)
3% less funds holding
Funds holding: 58 → 56 (-2)
9% less capital invested
Capital invested by funds: $28.2M → $25.6M (-$2.68M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$1.16M |
| 2 |
Mariner
Overland Park,
Kansas
|
+$980K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$464K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$388K |
| 5 |
G
GenTrust
Miami,
Florida
|
+$301K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$3.78M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$1.24M |
| 3 |
Renaissance Technologies
New York
|
-$272K |
| 4 |
Squarepoint
New York
|
-$140K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$117K |
KRON Hedge Fund Activity: Q2 2024 in Review
56 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q2 2024, worth a combined $25.6M — down 9.5% from $28.2M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of KRON and 6 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 16 added.
The largest buyer was Partners Capital Investment Group, adding an estimated $1.16M. The largest seller was BVF Inc, exiting entirely with an estimated $3.78M sold.
- 56 institutional investors held Kronos Bio (KRON) as of Q2 2024, down from 58 in Q1 2024.
- Funds reported $25.6M of Kronos Bio stock for Q2 2024, down 9.5% quarter-over-quarter.
- 6 funds opened new Kronos Bio positions in Q2 2024 and 8 closed out, a net change of -2 holders.
- The largest Kronos Bio buyer in Q2 2024 was Partners Capital Investment Group, an estimated $1.16M added.
- The largest Kronos Bio seller in Q2 2024 was BVF Inc, an estimated $3.78M sold.
Based on aggregated 13F filings for Q2 2024.